Genetics Generation Advancement Corp. (4160.TWO)

TWD 70.2

(-2.9%)

Inventory Summary of Genetics Generation Advancement Corp.

Genetics Generation Advancement Corp.'s latest annual inventory in 2023 was 34.79 Million TWD , up 11.21% from previous year.
Genetics Generation Advancement Corp.'s latest quarterly inventory in 2024 Q2 was 35.75 Million TWD , up 2.88% from previous quarter.
Genetics Generation Advancement Corp. reported annual inventory of 31.29 Million TWD in 2022, down -47.59% from previous year.
Genetics Generation Advancement Corp. reported annual inventory of 59.7 Million TWD in 2021, up 7.91% from previous year.
Genetics Generation Advancement Corp. reported quarterly inventory of 35.75 Million TWD for 2024 Q2, up 2.88% from previous quarter.
Genetics Generation Advancement Corp. reported quarterly inventory of 34.79 Million TWD for 2023 FY, up 11.21% from previous quarter.

Annual Inventory Chart of Genetics Generation Advancement Corp. (2023 - 2019)

Historical Annual Inventory of Genetics Generation Advancement Corp. (2023 - 2019)

Year	Inventory	Inventory Growth
2023	34.79 Million TWD	11.21%
2022	31.29 Million TWD	-47.59%
2021	59.7 Million TWD	7.91%
2020	55.33 Million TWD	-26.32%
2019	75.1 Million TWD	0.0%

Year	Inventory	Inventory Growth
2024 Q1	34.75 Million TWD	-0.12%
2024 Q2	35.75 Million TWD	2.88%
2023 FY	34.79 Million TWD	11.21%
2023 Q4	34.79 Million TWD	13.77%
2023 Q3	30.58 Million TWD	-9.5%
2023 Q2	33.79 Million TWD	2.57%
2023 Q1	32.94 Million TWD	0.0%
2022 Q4	- TWD	0.0%
2022 FY	31.29 Million TWD	-47.59%
2021 FY	59.7 Million TWD	7.91%
2020 FY	55.33 Million TWD	0.0%

Peer Inventory Comparison of Genetics Generation Advancement Corp.

Name	Inventory	Inventory Difference
BIONET Corp.	55.53 Million TWD	37.344%
DIVA Laboratories, Ltd.	196.2 Million TWD	82.264%
Welgene Biotech Co.,Ltd.	53.77 Million TWD	35.284%
Puriblood Medical Co., Ltd.	24.24 Million TWD	-43.515%
TFBS Bioscience Inc.	8.84 Million TWD	-293.509%